Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.770
-0.070 (-3.80%)
At close: Apr 28, 2026, 4:00 PM EDT
1.789
+0.018 (1.05%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $272.97 million as of April 28, 2026. Its market cap has increased by 217.40% in one year.
Market Cap
272.97M
Enterprise Value
155.20M
1-Year Change
217.40%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $272.97M, a decrease of -32.47%. That is a compound annual growth rate of -3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 275.80M | 60.72% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 293.65M |
| Cellectis | 291.55M |
| Sagimet Biosciences | 284.47M |
| Minerva Neurosciences | 280.59M |
| NovaBridge Biosciences | 278.13M |
| C4 Therapeutics | 272.73M |
| Protara Therapeutics | 270.42M |
| Eledon Pharmaceuticals | 267.02M |